Cargando…
A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer
Cancer is a heterogeneous disease mainly driven by abnormal gene perturbations in regulatory networks. Therefore, it is appealing to identify the common and specific perturbed genes from multiple cancer networks. We developed an integrative network medicine approach to identify novel biomarkers and...
Autores principales: | Zhang, Le, Fan, Shiwei, Vera, Julio, Lai, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732137/ https://www.ncbi.nlm.nih.gov/pubmed/36514340 http://dx.doi.org/10.1016/j.csbj.2022.11.037 |
Ejemplares similares
-
Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs
por: Niculescu, A. B., et al.
Publicado: (2019) -
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
por: Morselli Gysi, Deisy, et al.
Publicado: (2020) -
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
por: Morselli Gysi, Deisy, et al.
Publicado: (2021) -
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation
por: Lal, Jessica C., et al.
Publicado: (2022) -
Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing
por: de Anda-Jáuregui, Guillermo, et al.
Publicado: (2018)